Squamous cell carcinoma of the anal sac in two cats

This report describes two cases of feline anal sac squamous cell carcinoma. Cat 1 was managed with a multimodal approach combining surgical resection, radiation therapy and systemic therapy (toceranib phosphate; Palladia™) until local recurrence was identified at 236 days postsurgery. At that time,...

Full description

Saved in:
Bibliographic Details
Published inJournal of small animal practice Vol. 62; no. 8; pp. 704 - 708
Main Authors Kopke, M. A., Gal, A., Piripi, S. A., Poirier, V. J.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2021
Wiley Subscription Services, Inc
Subjects
Cancer
Carboplatin
Differential diagnosis
Inflammation
Meloxicam
Quality of life
Radiation therapy
Squamous cell carcinoma
Tumors
Online AccessGet full text

Cover

More Information
Summary:This report describes two cases of feline anal sac squamous cell carcinoma. Cat 1 was managed with a multimodal approach combining surgical resection, radiation therapy and systemic therapy (toceranib phosphate; Palladia™) until local recurrence was identified at 236 days postsurgery. At that time, the cat received carboplatin. With the tumour being progressive, the cat was euthanased 552 days post initial surgery. Cat 2 was managed palliatively with a non‐steroidal anti‐inflammatory (meloxicam) and supportive medications. Unfortunately, with further decline in quality of life following initial diagnosis, the cat was euthanased 28 days later. Squamous cell carcinoma should be considered as a possible differential diagnosis when a cat is presented for investigation of an anal sac mass.
ISSN:0022-4510
1748-5827
DOI:10.1111/jsap.13217